We are live on ! Find out more
CCM

Compass Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 12.1%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+12.1%
3 Year Est. Return
+50.82%
5 Year Est. Return
+57.89%
10 Year Est. Return
+257.31%
AUM
$523M
AUM Growth
+$20.8M
Cap. Flow
+$12.5M
Cap. Flow %
2.4%
Top 10 Hldgs %
41.63%
Holding
44
New
2
Increased
22
Reduced
13
Closed
3

Top Sells

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$19.5M
2
MDT icon
Medtronic
MDT
+$18.7M
3
SYK icon
Stryker
SYK
+$1.1M
4
BCR
CR Bard Inc.
BCR
+$942K
5
CAG icon
Conagra Brands
CAG
+$447K

Sector Composition

Rank Sector Weight
1 Healthcare 28.94%
2 Industrials 23.18%
3 Technology 18.84%
4 Consumer Staples 8.28%
5 Materials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCR
1
DELISTED
CR Bard Inc.
BCR
$22.9M 4.37%
97,243
-4,339
-4% -$942K
SYK icon
2
Stryker
SYK
$111B
$22.7M 4.34%
189,434
-9,872
-5% -$1.1M
JNJ icon
3
Johnson & Johnson
JNJ
$645B
$22M 4.21%
181,625
+238
+0.1% +$27K
SHW icon
4
Sherwin-Williams
SHW
$79.4B
$21.7M 4.14%
221,325
-783
-0.4% -$76.3K
DHR icon
5
Danaher
DHR
$147B
$21.6M 4.14%
318,761
-793
-0.2% -$51.9K
ITW icon
6
Illinois Tool Works
ITW
$76.9B
$21.5M 4.11%
206,206
-2,492
-1% -$261K
TMO icon
7
Thermo Fisher Scientific
TMO
$240B
$21.3M 4.07%
144,202
-1,723
-1% -$254K
ACN icon
8
Accenture
ACN
$117B
$21.2M 4.06%
187,376
-1,139
-0.6% -$132K
ECL icon
9
Ecolab
ECL
$77.5B
$20.9M 3.99%
175,873
+3,991
+2% +$465K
JCI icon
10
Johnson Controls International
JCI
$85.2B
$20.6M 3.93%
443,902
+21,209
+5% +$935K
NVS icon
11
Novartis
NVS
$264B
$20.4M 3.9%
275,872
+36,655
+15% +$2.53M
MSFT icon
12
Microsoft
MSFT
$3.66T
$20.1M 3.85%
393,598
+19,400
+5% +$1.01M
WMT icon
13
Walmart Inc
WMT
$860B
$20.1M 3.84%
824,820
+7,656
+0.9% +$177K
CVS icon
14
CVS Health
CVS
$119B
$19.9M 3.81%
208,052
+10,077
+5% +$1M
FAST icon
15
Fastenal
FAST
$57B
$19.8M 3.79%
1,787,112
+75,520
+4% +$863K
EXPD icon
16
Expeditors International
EXPD
$24.8B
$19.8M 3.79%
404,316
+12,622
+3% +$613K
V icon
17
Visa
V
$693B
$19.7M 3.76%
265,219
+5,321
+2% +$417K
GWW icon
18
W.W. Grainger
GWW
$60B
$19.6M 3.75%
86,250
+2,792
+3% +$636K
ORCL icon
19
Oracle
ORCL
$432B
$19.4M 3.71%
473,504
+14,053
+3% +$561K
FDX icon
20
FedEx
FDX
$72.1B
$19.1M 3.65%
125,766
+1,582
+1% +$257K
QCOM icon
21
Qualcomm
QCOM
$200B
$19.1M 3.65%
356,241
+23,132
+7% +$1.22M
PG icon
22
Procter & Gamble
PG
$344B
$19M 3.63%
224,519
+5,668
+3% +$465K
CHKP icon
23
Check Point Software Technologies
CHKP
$14B
$18.5M 3.53%
+232,015
New +$19.4M
BEN icon
24
Franklin Templeton
BEN
$16.9B
$17.5M 3.34%
524,118
+53,486
+11% +$1.94M
CAG icon
25
Conagra Brands
CAG
$7.3B
$1.82M 0.35%
48,914
-12,548
-20% -$447K

Similar funds

Compass Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Compass Capital Management held 44 positions worth $523M, up 4.1% from $502M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Compass Capital Management's Q2 2016 filing shows 2 new, 22 increased, 13 reduced and 3 closed positions. Its largest new stake was Check Point Software Technologies: 232,015 shares worth $18.5M. The largest sale was Automatic Data Processing, an estimated $19.5M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Industrials and Technology.

  • Compass Capital Management's largest Q2 2016 buy was Check Point Software Technologies: 232,015 shares worth $18.5M.
  • Compass Capital Management added most to Novartis in Q2 2016, an estimated $2.53M increase.
  • Compass Capital Management's biggest Q2 2016 reduction was Stryker, cutting an estimated $1.1M.
  • Compass Capital Management fully exited Automatic Data Processing in Q2 2016, selling an estimated $19.5M.
  • Compass Capital Management's ten largest holdings make up 42% of its $523M portfolio in Q2 2016.
  • Compass Capital Management opened 2 new positions and closed 3 in Q2 2016.
  • Compass Capital Management's portfolio value rose 4.1% quarter-over-quarter to $523M.

Based on Compass Capital Management's 13F filing for Q2 2016, filed 28 Jul 2016.